Page last updated: 2024-08-22

sulfur hexafluoride and Age-Related Macular Degeneration

sulfur hexafluoride has been researched along with Age-Related Macular Degeneration in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (12.12)18.2507
2000's19 (57.58)29.6817
2010's8 (24.24)24.3611
2020's2 (6.06)2.80

Authors

AuthorsStudies
Bayoumy, ASM; Elmohamady, MN; Faramawi, HM; Khalil, MTI; Rateb, M1
Agarwal, A; Aggarwal, K; Gupta, V; Handa, S; Markan, A1
Byeon, SH; Choi, HJ; Choi, M; Chung, B; Lee, J; Shin, JY1
Karska-Basta, I; Kubicka-Trząska, A; Miniewicz, J; Romanowska-Dixon, B1
Abboud, M; Benzerroug, M; Milazzo, S1
Hattenbach, LO; Höhn, F; Mirshahi, A1
Auriol, S; Lequeux, L; Mahieu, L; Pagot-Mathis, V; Quintyn, JC1
Gotoh, N; Hasegawa, T; Ooto, S; Otani, A; Sasahara, M; Tamura, H; Tsujikawa, A; Yamashiro, K; Yoshimura, N1
Beckford-Torngren, C; Benítez-Herreros, J; Cámara-González, C; Castro-Rebollo, M; Gros-Otero, J1
Hirano, Y; Ito, Y; Mizutani, T; Ogura, Y; Takase, A; Yasukawa, T; Yoshida, M1
Brieden, M; Gümbel, H; Hattenbach, LO; Koch, F1
Hesse, L; Schulze, SD1
Marek, J; Nizankowska, MH; Oficjalska-Młyńczak, J; Zajac-Pytrus, H1
Bornfeld, N; Foerster, MH; Gabel-Pfisterer, A; Heimann, H; Jandeck, C; Kellner, U; Laue, J1
Kittantong, A; Ratanasukon, M1
Heinzl, H; Mozaffarieh, M; Sacu, S; Wedrich, A1
Axer-Siegel, R; Ehrlich, R; Ron, Y; Rosenblatt, I; Weinberger, D1
Chen, MS; Fang, IM; Lin, YC; Yang, CH; Yang, CM1
Eter, N; Helb, HM; Holz, FG; Meyer, CH; Scholl, HP1
Jacobi, KW; Pavlovic, S; Scharwey, K1
Blodi, BA; Elner, SG; Hassan, AS; Johnson, MW; Poliner, LS; Regillo, CD; Schneiderman, TE; Tornambe, PE1
Jochmann, C; Meier, P; Wiedemann, P; Zeumer, C1
Daneshvar, H; Kertes, PJ; Leonard, BC; Peyman, GA1
Framme, C; Gabel, VP; Lohmann, CP; Roider, J; Sachs, HG; Spiegel, D; Toukhy, HE1
Krepler, K; Kruger, A; Stur, M; Tittl, M; Wedrich, A1
Heller, G; Hesse, L; Kroll, P; Schroeder, B1
Averbukh, E; Berger, AR; Devenyi, RG; Lam, WC1
Hesse, L; Kroll, P1
Hay, SR; Madonna, RJ1
Cox, TA; Fekrat, S; Haupert, CL; Jaffe, GJ; McCuen, BW; Postel, EA; Steuer, ER; Toth, CA1
Gümbel, HO; Hattenbach, LO; Klais, C; Koch, FH1
Abe, T; Kano, T; Tamai, M; Yoshida, M1
Lewis, H1

Trials

3 trial(s) available for sulfur hexafluoride and Age-Related Macular Degeneration

ArticleYear
[Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010, Volume: 107, Issue:4

    Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Vitreous Body

2010
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Ophthalmology, 1999, Volume: 106, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm; Eye Injuries; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Postoperative Complications; Prone Position; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body

1999
Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Retina (Philadelphia, Pa.), 2000, Volume: 20, Issue:3

    Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body

2000

Other Studies

30 other study(ies) available for sulfur hexafluoride and Age-Related Macular Degeneration

ArticleYear
Sulphur hexafluoride (SF6) intravitreal injection combined with argon laser photocoagulation for treatment of optic disc pit maculopathy.
    Eye (London, England), 2021, Volume: 35, Issue:2

    Topics: Argon; Follow-Up Studies; Humans; Intravitreal Injections; Lasers; Macular Degeneration; Optic Disk; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vitrectomy

2021
Subretinal Hemorrhage Complicating Retinal Angiomatous Proliferation in Tubercular Retinal Vasculitis.
    Ocular immunology and inflammation, 2022, Feb-17, Volume: 30, Issue:2

    Topics: Adult; Cell Proliferation; Fibrinolytic Agents; Fluorescein Angiography; Humans; Macular Degeneration; Male; Retinal Hemorrhage; Retinal Vasculitis; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy

2022
Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage.
    Optometry and vision science : official publication of the American Academy of Optometry, 2016, Volume: 93, Issue:2

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity

2016
[Managment of subretinal heamorrhages within the macular area using intravitreal injections of recombined tissue plasminogen activator, sulphur hexafluoride and ranihizumab--preliminary report].
    Klinika oczna, 2015, Volume: 117, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Middle Aged; Ranibizumab; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Young Adult

2015
[Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
    Journal francais d'ophtalmologie, 2017, Volume: 40, Issue:2

    Topics: Aged; Aged, 80 and over; Bevacizumab; Female; Hematoma; Humans; Intravitreal Injections; Macular Degeneration; Male; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy

2017
[Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Journal francais d'ophtalmologie, 2010, Volume: 33, Issue:2

    Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fibrinolytic Agents; Fluorescein Angiography; France; Hematoma; Humans; Injections, Intraocular; Macular Degeneration; Male; Photochemotherapy; Prognosis; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy

2010
Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
    American journal of ophthalmology, 2010, Volume: 149, Issue:2

    Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Lens Implantation, Intraocular; Macular Degeneration; Male; Middle Aged; Phacoemulsification; Photochemotherapy; Prognosis; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Vitreous Hemorrhage

2010
[Management of subretinal hemorrhage with r-TPA, SF-6 and ranibizumab].
    Archivos de la Sociedad Espanola de Oftalmologia, 2010, Volume: 85, Issue:3

    Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Injections, Intraocular; Macular Degeneration; Male; Paracentesis; Ranibizumab; Recombinant Proteins; Recurrence; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitreous Body

2010
Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2011, Volume: 249, Issue:8

    Topics: Aged; Aged, 80 and over; Aneurysm, Ruptured; Angiogenesis Inhibitors; Combined Modality Therapy; Fibrinolytic Agents; Follow-Up Studies; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Middle Aged; Photochemotherapy; Prone Position; Recurrence; Retinal Artery; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity

2011
[Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
    Klinische Monatsblatter fur Augenheilkunde, 2002, Volume: 219, Issue:7

    Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Middle Aged; Ophthalmoscopy; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body

2002
Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2002, Volume: 240, Issue:9

    Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body

2002
[Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
    Klinika oczna, 2003, Volume: 105, Issue:3-4

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity

2003
Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:4

    Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Macular Degeneration; Male; Membranes; Middle Aged; Prognosis; Recurrence; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Visual Acuity; Vitrectomy

2004
Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
    Eye (London, England), 2005, Volume: 19, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Fluorocarbons; Follow-Up Studies; Gases; Humans; Macular Degeneration; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Thailand; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity

2005
In-patient management and treatment satisfaction after intravitreous plasminogen activator injection.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:11

    Topics: Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections; Inpatients; Macular Degeneration; Patient Satisfaction; Prone Position; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Surveys and Questionnaires; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body

2006
Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2007, Volume: 221, Issue:1

    Topics: Aged; Aged, 80 and over; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Visual Acuity

2007
Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
    Eye (London, England), 2009, Volume: 23, Issue:2

    Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Gases; Humans; Macular Degeneration; Male; Middle Aged; Prognosis; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body

2009
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
    Acta ophthalmologica, 2008, Volume: 86, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body

2008
[Early posterior capsule fibrosis after combined cataract and vitreoretinal surgery with intraocular air/SF6 gas tamponade].
    Klinische Monatsblatter fur Augenheilkunde, 1998, Volume: 212, Issue:3

    Topics: Aged; Air; Cataract; Eye Diseases; Female; Fibrosis; Follow-Up Studies; Humans; Lens Capsule, Crystalline; Lenses, Intraocular; Macular Degeneration; Male; Phacoemulsification; Postoperative Complications; Reoperation; Retinal Diseases; Retrospective Studies; Sulfur Hexafluoride; Vitrectomy; Vitreous Body

1998
[Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1999, Volume: 96, Issue:10

    Topics: Aged; Electroretinography; Female; Fibrinolytic Agents; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Laser Coagulation; Macular Degeneration; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body

1999
Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1999, Volume: 34, Issue:7

    Topics: Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Pilot Projects; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Visual Acuity; Vitreous Body

1999
[Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
    Klinische Monatsblatter fur Augenheilkunde, 2000, Volume: 216, Issue:1

    Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Female; Humans; Laser Coagulation; Macular Degeneration; Male; Middle Aged; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vitreous Body

2000
Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
    Retina (Philadelphia, Pa.), 2000, Volume: 20, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body

2000
Pneumatic displacement of submacular hemorrhage.
    Ophthalmology, 2000, Volume: 107, Issue:12

    Topics: Humans; Macula Lutea; Macular Degeneration; Plasminogen Activators; Retinal Hemorrhage; Retinal Vessels; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity

2000
Pneumatic displacement of submacular hemorrhage.
    Ophthalmology, 2000, Volume: 107, Issue:12

    Topics: Fibrinolytic Agents; Humans; Injections; Macula Lutea; Macular Degeneration; Retinal Hemorrhage; Retinal Vessels; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity

2000
Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Optometry (St. Louis, Mo.), 2000, Volume: 71, Issue:11

    Topics: Aged; Humans; Injections; Macular Degeneration; Male; Plasminogen Activators; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body

2000
Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    American journal of ophthalmology, 2001, Volume: 131, Issue:2

    Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections; Macular Degeneration; Male; Recurrence; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy

2001
Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
    Ophthalmology, 2001, Volume: 108, Issue:8

    Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Plasminogen Activators; Prone Position; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Safety; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body

2001
Visual function after removal of subretinal neovascular membranes in patients with age-related macular degeneration.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2001, Volume: 239, Issue:12

    Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fibrosis; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Pigment Epithelium of Eye; Postoperative Care; Silicone Oils; Sulfur Hexafluoride; Visual Acuity; Visual Field Tests; Visual Fields; Vitrectomy

2001
tPA and gas in submacular hemorrhage.
    Ophthalmology, 2002, Volume: 109, Issue:5

    Topics: Fibrinolytic Agents; Humans; Injections; Macular Degeneration; Prognosis; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity

2002